Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Supporting your high street Find out how »
Tamoxifen and Breast Cancer, Paperback / softback Book

Tamoxifen and Breast Cancer Paperback / softback

Part of the Yale Fastback Series series

Paperback / softback

Available to Order - This title is available to order, with delivery expected within 2 weeks

Description

Tamoxifen is one of the most widely prescribed drugs used to prevent the recurrence of breast cancer.

A nonsteroidal antiestrogen, it has been successful in treating postmenopausal women at nearly all stages of breast cancer.

Despite its popularity, disturbing questions remain about the use of this drug.

How effective is tamoxifen in treating patients who have hormone-insensitive breast tumors or who have not yet reached menopause?

What are the potential risks in taking tamoxifen, and do they ever outweigh its benefits?

Should tamoxifen be administered as a prophylactic drug for healthy premenopausal women who are at high risk of developing breast cancer?

In this vitally important book, two leading scientific investigators present a balanced and accessible discussion of the diagnosis of breast cancer and the risks, benefits, and limitations of treatment alternatives, particularly tamoxifen.

Michael W. DeGregorio and Valerie J. Wiebe discuss the history and evolution of tamoxifen as a treatment for breast cancer, explaining how it works, what its side effects are, and why tamoxifen treatment is unsuccessful for some women.

They present the controversies surrounding the National Cancer Institute's study of tamoxifen as a preventive for breast cancer, describing the hopes of the proponents of the study and the fears of its detractors (potential risks to women in the study include thrombosis, uterine cancer, and even breast cancer itself).

The book is an invaluable aid to women faced with decisions about treatment or prevention of breast cancer.

Information

£12.00

Available to Order - This title is available to order, with delivery expected within 2 weeks
Add to Basket
Sign in to add to wishlist
 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information

Also in the Yale Fastback Series series  |  View all

Sexual Harassment of Working Women

£30.00

Add to Basket

Who Votes?

£15.00

Add to Basket

Medicine's Dilemmas

£21.00

Add to Basket

We the Poor People

£22.00

Add to Basket